University of Kentucky

Daniel Carl Lee

Associate professor9 Sept 2026reporter.nih.gov

Xian Wu

3 Sept 2026reporter.nih.gov

David C Zhu

31 Aug 2026reporter.nih.gov

Rong Zhang

31 Aug 2026reporter.nih.gov

Ann Marie Stowe

Professor31 Aug 2026reporter.nih.gov

DWIGHT C. German

31 Aug 2026reporter.nih.gov

GYeon Oh

Assistant professor28 Aug 2026reporter.nih.gov

Linda J Van Eldik

Director, sanders-brown center on aging28 Aug 2026reporter.nih.gov

Jonathan Michael Zuidema

Assistant professor26 Aug 2026reporter.nih.gov

Stephen A Murray

18 Aug 2026reporter.nih.gov

Lance Allen Johnson

Assistant professor18 Aug 2026reporter.nih.gov

Ashley Winn Seifert

Professor14 Aug 2026reporter.nih.gov

Barbara Nikolajczyk

Professor3 Aug 2026reporter.nih.gov

Simon J Fisher

Profesor3 Aug 2026reporter.nih.gov

Michael Paul Murphy

28 Jul 2026reporter.nih.gov

Anika M.S. Hartz

Phd22 Jul 2026reporter.nih.gov

Robyn S. Allen

Postdoctoral scholar20 Jul 2026reporter.nih.gov

Craig van Horne

Professor and chair25 Jun 2026reporter.nih.gov

John T. Slevin

Professor of neurology25 Jun 2026reporter.nih.gov

Jorge E Quintero

Research assistant professor25 Jun 2026reporter.nih.gov

NCT02239913

Phase 1Completed201438 people15 Sept 2014clinicaltrials.gov

NCT02141620

Early phase 1Completed201415 people19 May 2014clinicaltrials.gov

NCT02048917

Phase 1Completed201493 people29 Jan 2014clinicaltrials.gov

NCT01488227

Phase 3Completed201145 people8 Dec 2011clinicaltrials.gov

NCT00818389

CollaboratorPhase 2/3Terminated200984 people7 Jan 2009clinicaltrials.gov

NCT00630396

CollaboratorPhase 1/2Completed200860 people7 Mar 2008clinicaltrials.gov

NCT00237575

Phase 3Terminated2005100 people12 Oct 2005clinicaltrials.gov

NCT00176293

Phase 2Terminated20052 people15 Sept 2005clinicaltrials.gov

National Institute on Aging

R01Emerging Role of GPRC6a Variants in Alzheimer’s disease and TauopathiesR01AG100290US$646.7k2026–20319 Sept 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

K99Clinical Prediction, Genetic Architecture, and Environmental Modification in Alzheimer’s Disease, LATE, and Mixed PathologyK99NS150925US$124.9k2026–20273 Sept 2026reporter.nih.gov

National Institute on Aging

R01Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" TrialR01AG084134US$742.4k2023–202731 Aug 2026reporter.nih.gov

National Institute on Aging

R00Gabapentin prescription and health-related outcomes in older adultsR00AG084892US$249k2023–202928 Aug 2026reporter.nih.gov

National Institute on Aging

P30University of Kentucky Alzheimer's Disease Research CenterP30AG072946US$4.4m2021–203128 Aug 2026reporter.nih.gov

National Institute on Aging

R21Multiscale Microgels Delivering GDNF and Agrin with Resistance Training to Enhance Outcomes in SarcopeniaR21AG095587US$590.8k2026–202926 Aug 2026reporter.nih.gov

National Institute on Aging

R01Base Editing of APOE4 for Alzheimer's DiseaseR01AG103924US$712.9k2026–203118 Aug 2026reporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

R01Deciphering how tissue resident macrophages regulate musculoskeletal regeneration in spiny miceR01AR070313US$541.7k2017–202914 Aug 2026reporter.nih.gov

National Institute of General Medical Sciences

P20University of Kentucky Diabetes Prevention COBREP20GM156679US$2.3m2025–20303 Aug 2026reporter.nih.gov

National Institute on Aging

T32Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)T32AG078110US$278.6k2022–202728 Jul 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s DiseaseR01NS133250US$716.5k2023–202822 Jul 2026reporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

F32A multispecies system for elucidating proliferative control mechanisms during mammalian skin and musculoskeletal regenerationF32AR083259US$86.6k2024–202720 Jul 2026reporter.nih.gov

National Institute on Aging

R01Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimer’s DiseaseR01AG081356US$674.2k2024–202925 Jun 2026reporter.nih.gov

National Heart, Lung, and Blood Institute

R01Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in FemalesR01HL163589US$707.5k2024–202819 Jun 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01The role of macrophage metabolism and age in recovery from spinal cord injuryR01NS126228US$540.9k2023–202816 Jun 2026reporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

R01Regulation of Myonuclear Turnover Dynamics in Multinucleated Muscle CellsR01AR084850US$529k2025–203012 Jun 2026reporter.nih.gov

National Institute on Aging

R01Impacting Inflammation through Mechanistic Target of Rapamycin (imTOR)R01AG084180US$611.8k2024–202826 May 2026reporter.nih.gov

National Institute of Environmental Health Sciences

R01Radon on the RADARR01ES030380US$514.5k2020–202926 May 2026reporter.nih.gov

National Institute of Child Health and Human Development

R01Harnessing the inflammatory response to promote regeneration in mammalsR01HD116735US$657.6k2025–203027 Apr 2026reporter.nih.gov

National Institute on Aging

R01Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology DementiaR01AG082339US$84.6k2023–20287 Apr 2026reporter.nih.gov